At CRISPR Therapeutics, we are focused on developing gene-based medicines with the potential to transform the lives of people with serious diseases. We recognize that patients are central to our mission, and understanding their needs is a critical first step to our success. We are committed to learning from people who live with and are impacted by the complex conditions we are researching. CRISPR has a portfolio of investigational programs across a broad range of therapeutic areas including oncology, hemoglobinopathies, diabetes, and other rare diseases. Visit us at crisprtx.com.
CRISPR Therapeutics’ gene-editing approach is still being investigated in clinical trials, and its safety and efficacy have not been established. Any information about investigational products have not been approved by any health authority. There is no guarantee that any investigational product will successfully complete clinical development or gain FDA approval. Nothing provided herein is intended to suggest any treatment effect. Information in this booth is for educational purpose only. Always talk to your doctor about any questions. Intended for a U.S. audience only.
CRISPR Therapeutics’ gene-editing approach is still being investigated in clinical trials, and its safety and efficacy have not been established. It is not approved for use in patients in the United States or in any other countries.
Engage With The Exhibitor
Please use the box above to give feedback to the exhibitor by answering four questions.